Self and informant report ratings of psychopathology in genetic generalized epilepsy

Publication date: February 2017Source:Epilepsy & Behavior, Volume 67
Author(s): Amy Loughman, Stephen C. Bowden, Wendyl J. D’Souza
The psychological sequelae of genetic generalized epilepsies (GGE) is of growing research interest, with up to a third of all adults with GGE experiencing significant psychiatric comorbidity according to a recent systematic review. A number of unexplored questions remain. Firstly, there is insufficient evidence to determine relative prevalence ...

Seguir leyendo →
0

‘Epileptic’, ‘epileptic person’ or ‘person with epilepsy’? Bringing quantitative and qualitative evidence on the views of UK patients and carers to the terminology debate

Publication date: February 2017Source:Epilepsy & Behavior, Volume 67
Author(s): Adam J. Noble, Abbey Robinson, Darlene Snape, Anthony G. Marson
How to refer to someone with epilepsy is a divisive topic. Arguments for and against different approaches, including traditional adjective labels, disability-first labels, and person-first terms have been presented. The preferences of those with epilepsy and their family and friends have, though, never been ...

Seguir leyendo →
0

Disclosure management behaviors in Korean adults with well-controlled epilepsy: Their relation to perception of stigma

Publication date: February 2017Source:Epilepsy & Behavior, Volume 67
Author(s): Sang-Ahm Lee, Byung-In Lee

Purpose
In spite of the fact that epilepsy is a concealable stigmatized identity, there is little evidence pertaining to disclosure management in adults living with epilepsy. We determined the factors contributing to disclosure management strategies in adults living with well-controlled epilepsy.
Methods
This was a cross-sectional multicenter study. Korean adults whose seizures had ...

Seguir leyendo →
0

Sudden unexpected death in epilepsy (SUDEP) disclosure in pediatric epilepsy: An Italian survey on “to tell or not to tell”

Publication date: February 2017Source:Epilepsy & Behavior, Volume 67
Author(s): Galli Federica, Vignoli Aglaia, Canevini Maria Paola, Cerioli Gabriele, Vegni Elena

Background and objectives
Although there has recently been significant debate regarding the importance of disclosing the risk of SUDEP, professional societies and clinical practice guidelines currently recommend that the risk of SUDEP be disclosed as part of a comprehensive epilepsy education program. ...

Seguir leyendo →
0

Pharmacists' knowledge of issues in pharmacotherapy of epilepsy using antiepileptic drugs: A cross-sectional study in Palestinian pharmacy practice

Publication date: February 2017Source:Epilepsy & Behavior, Volume 67
Author(s): Ramzi Shawahna, Ahlam Atrash, Aman Jebril, Areen Khalaf, Eman Shaheen, Hala Tahboosh

Objective
Antiepileptic drugs (AEDs) are mainstay in controlling epileptic seizures. As experts in medications, pharmacists should be able to ensure accuracy of dosing regimens, explain adverse effects, and screen for and alert people with epilepsy (PWE) and their physicians ...

Seguir leyendo →
0

The influence of patient, caregiver, and family factors on symptoms of anxiety and depression in children and adolescents with intractable epilepsy

Publication date: February 2017Source:Epilepsy & Behavior, Volume 67
Author(s): Klajdi Puka, Elysa Widjaja, Mary Lou Smith

Objective
The objective was to evaluate the association of caregiver and family factors with symptoms of anxiety and depression in children and adolescents with medically refractory localization-related epilepsy (i.e., failed at least two epilepsy medications).
Method
Forty-four children (ages 6–11years) and 65 adolescents (ages 12–18years) and ...

Seguir leyendo →
0

Maintenance effects of working memory intervention (Cogmed) in children with symptomatic epilepsy

Publication date: February 2017Source:Epilepsy & Behavior, Volume 67
Author(s): Amanda Fuentes, Elizabeth N. Kerr

Purpose
To extend previous research documenting the benefits of working memory (WM) intervention (Cogmed) immediately post-intervention in children with epilepsy by assessing the 3-month maintenance effects.
Methods
Participants involved in a previous randomized clinical trial (RCT) were invited to participate if they completed Cogmed within the last 3months (n=15) ...

Seguir leyendo →
0

Female sexual function mediates the effects of medication adherence on quality of life in people with epilepsy

Publication date: February 2017Source:Epilepsy & Behavior, Volume 67
Author(s): Chung-Ying Lin, Andrea Burri, Bengt Fridlund, Amir H. Pakpour

Purpose
The purpose of this study was to understand the mediating effects of female sexual functioning in the association between medication adherence and quality of life (QoL) in Iranian women with epilepsy (WWE).
Methods
Women’s sexual functioning was measured using Female Sexual Function Index; ...

Seguir leyendo →
0

Managing epilepsy-associated depression: Serotonin enhancers or serotonin producers?

Publication date: January 2017Source:Epilepsy & Behavior, Volume 66
Author(s): Tanveer Singh, Rajesh Kumar Goel
Depression is one of the major psychiatric comorbidities having a major impact on the quality of life in people with epilepsy (PWE). Selective serotonin reuptake inhibitors (SSRIs) are considered as safest therapy for the treatment of depression in PWE. Although administration of SSRIs increases the synaptic serotonin levels, it decreases the overall serotonin ...

Seguir leyendo →
0

Quality-of-life metrics with vagus nerve stimulation for epilepsy from provider survey data

Publication date: January 2017Source:Epilepsy & Behavior, Volume 66
Author(s): Dario J. Englot, Kevin H. Hassnain, John D. Rolston, Stephen C. Harward, Saurabh R. Sinha, Michael M. Haglund

Objective
Drug-resistant epilepsy is a devastating disorder associated with diminished quality of life (QOL). Surgical resection leads to seizure freedom and improved QOL in many epilepsy patients, but not all individuals are candidates ...

Seguir leyendo →
0
Página 15 de 18 «...101314151617...»